Intravenous Hydrogen Peroxide (IV H₂O₂)
IV Hydrogen Peroxide therapy involves very slow administration of highly diluted H₂O₂ (0.03–0.1%) directly into the bloodstream. Proponents claim it floods tissues with oxygen, selectively kills anaerobic organisms and cancer cells (which are known to be sensitive to oxidative stress), and stimulates immune function. This therapy has a long history in alternative medicine but lacks modern RCT evidence.
Mechanism of Action
H₂O₂ releases oxygen upon decomposition (catalysed by catalase/peroxidase enzymes in blood). The rapid oxygen release creates a transient hyperoxic environment. Cancer cells, which rely heavily on anaerobic glycolysis (Warburg effect) and have reduced antioxidant enzyme activity, are theoretically more vulnerable to oxidative stress than normal cells. However, the mechanism remains contested and dose-dependent.
Cancer Types Studied
Protocols & Dosing
Farr Protocol (Medical Clinic Only)
0.03% H₂O₂ in Ringer's lactate, IV drip over 1–3 hours. Start with 50 ml dose, gradually increasing. Administered ONLY under physician supervision with patient monitoring. Requires pharmacy-grade H₂O₂.
NIH / PubMed Research
Links open on PubMed (National Library of Medicine). Research is ongoing — results may not reflect clinical use.
Cautions & Contraindications
- DANGEROUS if self-administered — IV H₂O₂ can cause air embolism, vascular damage, and death if incorrectly administered
- NEVER use 35% 'food grade' H₂O₂ internally — causes severe burns, injury, death
- Only pharmaceutical-grade H₂O₂ at correct dilution under physician supervision
- Limited modern clinical evidence — experimental therapy with significant risks
- Contraindicated in heart disease, lung disease, and G6PD deficiency
- No formal clinical trial data — considered experimental by mainstream medicine
Informational only. Not medical advice. Consult your oncologist before starting any alternative or integrative therapy.